[Pharmacological properties of simeprevir (SOVRIAD® capsules 100 mg), a new drug for the treatment of hepatitis C, and results of its clinical studies]

Nihon Yakurigaku Zasshi. 2015 Feb;145(2):92-9. doi: 10.1254/fpj.145.92.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antiviral Agents / administration & dosage
  • Antiviral Agents / chemistry
  • Antiviral Agents / therapeutic use*
  • Capsules / administration & dosage
  • Capsules / therapeutic use
  • Clinical Trials as Topic
  • Hepatitis C / drug therapy*
  • Heterocyclic Compounds, 3-Ring / administration & dosage
  • Heterocyclic Compounds, 3-Ring / chemistry
  • Heterocyclic Compounds, 3-Ring / therapeutic use*
  • Humans
  • Simeprevir
  • Sulfonamides / administration & dosage
  • Sulfonamides / chemistry
  • Sulfonamides / therapeutic use*
  • Viral Nonstructural Proteins / chemistry
  • Viral Nonstructural Proteins / metabolism

Substances

  • Antiviral Agents
  • Capsules
  • Heterocyclic Compounds, 3-Ring
  • NS3 protein, hepatitis C virus
  • NS4 protein, hepatitis C virus
  • Sulfonamides
  • Viral Nonstructural Proteins
  • Simeprevir